Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology and therapeutics 2014-08, Vol.96 (2), p.156-157
Hauptverfasser:	Lanvers-Kaminsky, C, Malath, I, Deuster, D, Ciarimboli, G, Boos, J, am Zehnhoff-Dinnesen, A G
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents - toxicity Catechol O-Methyltransferase - genetics Cisplatin - toxicity Female Hearing Loss - chemically induced Humans Male Methyltransferases - genetics Multidrug Resistance-Associated Proteins - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	157
container_issue	2
container_start_page	156
container_title	Clinical pharmacology and therapeutics
container_volume	96
creator	Lanvers-Kaminsky, C Malath, I Deuster, D Ciarimboli, G Boos, J am Zehnhoff-Dinnesen, A G
description
doi_str_mv	10.1038/clpt.2014.67
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1548636012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1548636012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4477-ffbb0eacfa46ea893ab35e8b0be17f1694a681e10fcc4b3ca8bbdec9cb0f03633</originalsourceid><addsrcrecordid>eNp9kMFu1DAURS0EokNhxxplyYIMduzYzhJFpRQGGqpBSGws23mmppl4sB3o_D0JU7pk9XSlc--TDkLPCV4TTOVrO-zzusKErbl4gFakplXJa1o_RCuMcVM2FeUn6ElKP-bIGikfo5OKcVYJWq_Qt7Nfeph09mEsgiu6ax132obvMEL2tvio4w3EVORQdBF6b3ORr6G48ulmwVuf9sNcHsuLsZ8s9MVlDjnceuvz4Sl65PSQ4NndPUVf3p5t23fl5vL8on2zKS1jQpTOGYNBW6cZBy0bqg2tQRpsgAhHeMM0lwQIdtYyQ62WxvRgG2uww5RTeopeHnf3MfycIGW188nCMOgRwpQUqZnklGNSzeirI2pjSCmCU_vodzoeFMFqsakWm2qxqbiY8Rd3y5PZQX8P_9M3A-II_PYDHP47ptpu22667RL_TpfHpk8Zbu-bs-7lsajV10_nqvsgruTn7r0i9A_qGZLr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1548636012</pqid></control><display><type>article</type><title>Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Lanvers-Kaminsky, C ; Malath, I ; Deuster, D ; Ciarimboli, G ; Boos, J ; am Zehnhoff-Dinnesen, A G</creator><creatorcontrib>Lanvers-Kaminsky, C ; Malath, I ; Deuster, D ; Ciarimboli, G ; Boos, J ; am Zehnhoff-Dinnesen, A G</creatorcontrib><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2014.67</identifier><identifier>PMID: 24642735</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; Antineoplastic Agents - toxicity ; Catechol O-Methyltransferase - genetics ; Cisplatin - toxicity ; Female ; Hearing Loss - chemically induced ; Humans ; Male ; Methyltransferases - genetics ; Multidrug Resistance-Associated Proteins - genetics</subject><ispartof>Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.156-157</ispartof><rights>2014 American Society for Clinical Pharmacology and Therapeutics</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4477-ffbb0eacfa46ea893ab35e8b0be17f1694a681e10fcc4b3ca8bbdec9cb0f03633</citedby><cites>FETCH-LOGICAL-c4477-ffbb0eacfa46ea893ab35e8b0be17f1694a681e10fcc4b3ca8bbdec9cb0f03633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1038%2Fclpt.2014.67$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1038%2Fclpt.2014.67$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24642735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lanvers-Kaminsky, C</creatorcontrib><creatorcontrib>Malath, I</creatorcontrib><creatorcontrib>Deuster, D</creatorcontrib><creatorcontrib>Ciarimboli, G</creatorcontrib><creatorcontrib>Boos, J</creatorcontrib><creatorcontrib>am Zehnhoff-Dinnesen, A G</creatorcontrib><title>Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clinical Pharmacology & Therapeutics</addtitle><subject>Animals</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Catechol O-Methyltransferase - genetics</subject><subject>Cisplatin - toxicity</subject><subject>Female</subject><subject>Hearing Loss - chemically induced</subject><subject>Humans</subject><subject>Male</subject><subject>Methyltransferases - genetics</subject><subject>Multidrug Resistance-Associated Proteins - genetics</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAURS0EokNhxxplyYIMduzYzhJFpRQGGqpBSGws23mmppl4sB3o_D0JU7pk9XSlc--TDkLPCV4TTOVrO-zzusKErbl4gFakplXJa1o_RCuMcVM2FeUn6ElKP-bIGikfo5OKcVYJWq_Qt7Nfeph09mEsgiu6ax132obvMEL2tvio4w3EVORQdBF6b3ORr6G48ulmwVuf9sNcHsuLsZ8s9MVlDjnceuvz4Sl65PSQ4NndPUVf3p5t23fl5vL8on2zKS1jQpTOGYNBW6cZBy0bqg2tQRpsgAhHeMM0lwQIdtYyQ62WxvRgG2uww5RTeopeHnf3MfycIGW188nCMOgRwpQUqZnklGNSzeirI2pjSCmCU_vodzoeFMFqsakWm2qxqbiY8Rd3y5PZQX8P_9M3A-II_PYDHP47ptpu22667RL_TpfHpk8Zbu-bs-7lsajV10_nqvsgruTn7r0i9A_qGZLr</recordid><startdate>201408</startdate><enddate>201408</enddate><creator>Lanvers-Kaminsky, C</creator><creator>Malath, I</creator><creator>Deuster, D</creator><creator>Ciarimboli, G</creator><creator>Boos, J</creator><creator>am Zehnhoff-Dinnesen, A G</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201408</creationdate><title>Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity</title><author>Lanvers-Kaminsky, C ; Malath, I ; Deuster, D ; Ciarimboli, G ; Boos, J ; am Zehnhoff-Dinnesen, A G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4477-ffbb0eacfa46ea893ab35e8b0be17f1694a681e10fcc4b3ca8bbdec9cb0f03633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Catechol O-Methyltransferase - genetics</topic><topic>Cisplatin - toxicity</topic><topic>Female</topic><topic>Hearing Loss - chemically induced</topic><topic>Humans</topic><topic>Male</topic><topic>Methyltransferases - genetics</topic><topic>Multidrug Resistance-Associated Proteins - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lanvers-Kaminsky, C</creatorcontrib><creatorcontrib>Malath, I</creatorcontrib><creatorcontrib>Deuster, D</creatorcontrib><creatorcontrib>Ciarimboli, G</creatorcontrib><creatorcontrib>Boos, J</creatorcontrib><creatorcontrib>am Zehnhoff-Dinnesen, A G</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lanvers-Kaminsky, C</au><au>Malath, I</au><au>Deuster, D</au><au>Ciarimboli, G</au><au>Boos, J</au><au>am Zehnhoff-Dinnesen, A G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clinical Pharmacology & Therapeutics</addtitle><date>2014-08</date><risdate>2014</risdate><volume>96</volume><issue>2</issue><spage>156</spage><epage>157</epage><pages>156-157</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24642735</pmid><doi>10.1038/clpt.2014.67</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0009-9236
ispartof	Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.156-157
issn	0009-9236 1532-6535
language	eng
recordid	cdi_proquest_miscellaneous_1548636012
source	Wiley-Blackwell Journals; MEDLINE
subjects	Animals Antineoplastic Agents - toxicity Catechol O-Methyltransferase - genetics Cisplatin - toxicity Female Hearing Loss - chemically induced Humans Male Methyltransferases - genetics Multidrug Resistance-Associated Proteins - genetics
title	Evaluation of Pharmacogenetic Markers to Predict the Risk of Cisplatin-Induced Ototoxicity
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A28%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Pharmacogenetic%20Markers%20to%20Predict%20the%20Risk%20of%20Cisplatin-Induced%20Ototoxicity&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Lanvers-Kaminsky,%20C&rft.date=2014-08&rft.volume=96&rft.issue=2&rft.spage=156&rft.epage=157&rft.pages=156-157&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1038/clpt.2014.67&rft_dat=%3Cproquest_cross%3E1548636012%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1548636012&rft_id=info:pmid/24642735&rfr_iscdi=true